Science Advances

This PDF file includes:

• General Methods
• Fig. S1. Dose-dependent activation of SEAP signaling by analogs in HEK-Blue hTLR2 cells after 24 hours.
• Fig. S2. The MTT cell viability of HEK-Blue hTLR2 cells after 24 hours of incubation with CU-T12-9 and antibodies.
• Fig. S3. NO activation of CU-T12-9 can be suppressed by a TLR1/2 antagonist, but not by a TLR4 antagonist.
• Fig. S4. Anisotropy assays for TLR1, TLR2, or TLR1/2 protein binding to rhodamine-labeled Pam₃CSK₄ (Rho-Pam3).
• Fig. S5. Binding of CU-T12-9 to TLR1 by MST.
• Fig. S6. Binding of CU-T12-9 to TLR2 by MST.
• Fig. S7. TLR1 and TLR2 oligomeric states as seen by SEC-LS.
• Fig. S8. Concentration-dependent ¹H NMR experiments.
• Fig. S9. HEK-Blue hTLR2 and Raw 264.7 cell viability upon CU-T12-9 treatment.
• Fig. S10. Protein expression and characterization.
• Table S1. SAR studies of the GA analogs in activation of SEAP signaling in HEK-Blue hTLR2 cells.
• Scheme S1. General synthesis of TLR1/2 agonist GA.
• Synthesis and experimental data.
• References (52–54)

Download PDF